Results 151 to 160 of about 244,634 (196)

Pan-cancer molecular signatures connecting aspartate transaminase to cancer prognosis, metabolic and immune signatures. [PDF]

Front Oncol
Siwo GH, Singal AG, Waljee AK.
europepmc   +1 more source

Comprehensive pan-cancer analysis of AARS1, a newly identified lactyltransferase in human cancers. [PDF]

Cancer Cell Int
Fu T, Ni K, Wang Z, Sun S, Liu Y, Wan Q.
europepmc   +1 more source

Pan-cancer analysis identifies FKBP10 as a regulator of tumor immunosuppression and therapeutic response. [PDF]

Transl Oncol
Li Y, Chen J, Li S, Tu G, Tang L.
europepmc   +1 more source

Multi-omics analysis positions DNA2 at the interface of genome integrity programs and tumor behavior in pan-cancer. [PDF]

Funct Integr Genomics
Pandit D, Dhillon A, Chakrabarty S, Bilachi RS.   +3 more
europepmc   +1 more source

Pan-cancer analysis of OSR2 with a focus on underlying mechanisms and therapeutic implications in lung adenocarcinoma. [PDF]

Front Immunol
Liu S, Xiang X, Liu S, Peng W, Wang Z, Ye L, Zhou Q.   +6 more
europepmc   +1 more source

Unraveling the oncogenic and immunomodulatory roles of GINS1: a systematic pan-cancer study. [PDF]

Cancer Cell Int
Zhang X, Lei W, Pan Y, Zhong L, Zhai L, Li H, Liu B.   +6 more
europepmc   +1 more source

The role of CD26 in breast cancer and its pan-cancer analysis. [PDF]

BMC Cancer
Tao R, Liu B, Gao S, Zhang J, Wang J, Gong Q, Zhu X, Zhao Y, Huang J, Zhang C, Li Y, Wang Z, Zhang G.   +12 more
europepmc   +1 more source

Pan-cancer polygenic risk score associates with cancer susceptibility following kidney transplantation. [PDF]

JCI Insight
Ritari J, Hyvärinen K, Jahnukainen K, FinnGen Consortium, Partanen J, Helanterä I, Jahnukainen T.   +6 more
europepmc   +1 more source

Bioinformatics analysis of <i>PBLD</i> as a potential biomarker in pan-cancer and colon adenocarcinoma. [PDF]

Transl Cancer Res
Chen J, Chen X, Wei Y, Ou J, Yue L, Li X, Huang B, Zhi F, Zhao X.   +8 more
europepmc   +1 more source